NCT06864819View on ClinicalTrials.gov

Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UHCMC

RecruitingOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

May 5, 2025

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Postoperative ComplicationsAlcohol Use Disorder
Interventions
OTHER

Blood Draw

Patients will have a single blood sample sent for PEth testing, blood draws will happen during standard of care blood draw.

Trial Locations (1)

44106

RECRUITING

University Hospital, Cleveland

All Listed Sponsors
lead

University Hospitals Cleveland Medical Center

OTHER

NCT06864819 - Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UHCMC | Biotech Hunter | Biotech Hunter